Nasdaq

Sarepta Therapeutics Accepts CHMP's Negative Opinion For ELEVIDYS

(RTTNews) - Sarepta Therapeutics, Inc. (SRPT), Friday acknowledged the Committee for Medicinal Products for Human Use's negative opinion on the conditional marketing authorization for ELEVIDYS in ...
Forbes

Should Executives Interact With Critical Analysts During Earnings Calls?

According to a new research study, executives who choose to engage with analysts that are critical of their companies tend to change the analysts’ negative opinions, while also appearing more credible ...
JD Supra

OIG’s Advisory Opinion No. 25-08: Negative Opinion Highlights Potential Broad Reach of AKS

In a relatively rare move, the US Department of Health and Human Services Office of Inspector General (OIG) recently issued an unfavorable Advisory Opinion (No. 25-08) (Opinion) reinforcing the agency ...
Seeking Alpha

Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union

Partner Roche will continue its dialogue with the European Medicines Agency to explore a potential path forward to make ELEVIDYS available to individuals living with Duchenne muscular dystrophy in the ...
Seeking Alpha

EU panel declines backing Sarepta-Roche gene therapy for Duchenne

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) Friday said that an expert panel of the European Medicines Agency has issued a negative opinion on the conditional marketing authorization for Elevidys, intended for ...